IBDEI04S ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6085,0)
 ;;=401.1^^37^432^15
 ;;^UTILITY(U,$J,358.3,6085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6085,1,3,0)
 ;;=3^401.1
 ;;^UTILITY(U,$J,358.3,6085,1,4,0)
 ;;=4^HYPERTENSION,BENIGN
 ;;^UTILITY(U,$J,358.3,6085,2)
 ;;=^269591
 ;;^UTILITY(U,$J,358.3,6086,0)
 ;;=424.0^^37^432^16
 ;;^UTILITY(U,$J,358.3,6086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6086,1,3,0)
 ;;=3^424.0
 ;;^UTILITY(U,$J,358.3,6086,1,4,0)
 ;;=4^MITRAL REGURGITATION
 ;;^UTILITY(U,$J,358.3,6086,2)
 ;;=^78367
 ;;^UTILITY(U,$J,358.3,6087,0)
 ;;=394.0^^37^432^17
 ;;^UTILITY(U,$J,358.3,6087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6087,1,3,0)
 ;;=3^394.0
 ;;^UTILITY(U,$J,358.3,6087,1,4,0)
 ;;=4^MITRAL STENOSIS
 ;;^UTILITY(U,$J,358.3,6087,2)
 ;;=^78404
 ;;^UTILITY(U,$J,358.3,6088,0)
 ;;=424.0^^37^432^18
 ;;^UTILITY(U,$J,358.3,6088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6088,1,3,0)
 ;;=3^424.0
 ;;^UTILITY(U,$J,358.3,6088,1,4,0)
 ;;=4^MITRAL VALVE PROLAPSE
 ;;^UTILITY(U,$J,358.3,6088,2)
 ;;=^78367
 ;;^UTILITY(U,$J,358.3,6089,0)
 ;;=458.0^^37^432^19
 ;;^UTILITY(U,$J,358.3,6089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6089,1,3,0)
 ;;=3^458.0
 ;;^UTILITY(U,$J,358.3,6089,1,4,0)
 ;;=4^ORTHOSTATIC HYPOTENSION
 ;;^UTILITY(U,$J,358.3,6089,2)
 ;;=^60741
 ;;^UTILITY(U,$J,358.3,6090,0)
 ;;=785.1^^37^432^20
 ;;^UTILITY(U,$J,358.3,6090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6090,1,3,0)
 ;;=3^785.1
 ;;^UTILITY(U,$J,358.3,6090,1,4,0)
 ;;=4^PALPITATIONS
 ;;^UTILITY(U,$J,358.3,6090,2)
 ;;=^89281
 ;;^UTILITY(U,$J,358.3,6091,0)
 ;;=423.8^^37^432^21
 ;;^UTILITY(U,$J,358.3,6091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6091,1,3,0)
 ;;=3^423.8
 ;;^UTILITY(U,$J,358.3,6091,1,4,0)
 ;;=4^PERICARDIAL DISEASE NEC
 ;;^UTILITY(U,$J,358.3,6091,2)
 ;;=^269713
 ;;^UTILITY(U,$J,358.3,6092,0)
 ;;=443.89^^37^432^22
 ;;^UTILITY(U,$J,358.3,6092,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6092,1,3,0)
 ;;=3^443.89
 ;;^UTILITY(U,$J,358.3,6092,1,4,0)
 ;;=4^PERIPH VASCULAR DIS NEC
 ;;^UTILITY(U,$J,358.3,6092,2)
 ;;=^87788
 ;;^UTILITY(U,$J,358.3,6093,0)
 ;;=427.81^^37^432^23
 ;;^UTILITY(U,$J,358.3,6093,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6093,1,3,0)
 ;;=3^427.81
 ;;^UTILITY(U,$J,358.3,6093,1,4,0)
 ;;=4^SICK SINUS SYNDROME
 ;;^UTILITY(U,$J,358.3,6093,2)
 ;;=^110852
 ;;^UTILITY(U,$J,358.3,6094,0)
 ;;=780.2^^37^432^24
 ;;^UTILITY(U,$J,358.3,6094,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6094,1,3,0)
 ;;=3^780.2
 ;;^UTILITY(U,$J,358.3,6094,1,4,0)
 ;;=4^SYNCOPE
 ;;^UTILITY(U,$J,358.3,6094,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,6095,0)
 ;;=785.0^^37^432^25
 ;;^UTILITY(U,$J,358.3,6095,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6095,1,3,0)
 ;;=3^785.0
 ;;^UTILITY(U,$J,358.3,6095,1,4,0)
 ;;=4^TACHYCARDIA NOS
 ;;^UTILITY(U,$J,358.3,6095,2)
 ;;=^117041
 ;;^UTILITY(U,$J,358.3,6096,0)
 ;;=424.90^^37^432^26
 ;;^UTILITY(U,$J,358.3,6096,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6096,1,3,0)
 ;;=3^424.90
 ;;^UTILITY(U,$J,358.3,6096,1,4,0)
 ;;=4^VAVULAR HEART DISEASE
 ;;^UTILITY(U,$J,358.3,6096,2)
 ;;=^40327
 ;;^UTILITY(U,$J,358.3,6097,0)
 ;;=459.81^^37^432^27
 ;;^UTILITY(U,$J,358.3,6097,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6097,1,3,0)
 ;;=3^459.81
 ;;^UTILITY(U,$J,358.3,6097,1,4,0)
 ;;=4^VENOUS INSUFFICIENCY NOS
 ;;^UTILITY(U,$J,358.3,6097,2)
 ;;=^125826
 ;;^UTILITY(U,$J,358.3,6098,0)
 ;;=453.6^^37^432^28
 ;;^UTILITY(U,$J,358.3,6098,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6098,1,3,0)
 ;;=3^453.6
 ;;^UTILITY(U,$J,358.3,6098,1,4,0)
 ;;=4^VENOUS THROMBOSIS,LOWER EXTREMITY
 ;;^UTILITY(U,$J,358.3,6098,2)
 ;;=^338243
 ;;^UTILITY(U,$J,358.3,6099,0)
 ;;=453.83^^37^432^29
 ;;^UTILITY(U,$J,358.3,6099,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6099,1,3,0)
 ;;=3^453.83
 ;;^UTILITY(U,$J,358.3,6099,1,4,0)
 ;;=4^VENOUS THROMBOSIS,UPPER EXTREMITY
 ;;^UTILITY(U,$J,358.3,6099,2)
 ;;=^338254
 ;;^UTILITY(U,$J,358.3,6100,0)
 ;;=280.9^^37^433^3
 ;;^UTILITY(U,$J,358.3,6100,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6100,1,3,0)
 ;;=3^280.9
 ;;^UTILITY(U,$J,358.3,6100,1,4,0)
 ;;=4^ANEMIA,IRON DEFIC
 ;;^UTILITY(U,$J,358.3,6100,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,6101,0)
 ;;=285.21^^37^433^1
 ;;^UTILITY(U,$J,358.3,6101,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6101,1,3,0)
 ;;=3^285.21
 ;;^UTILITY(U,$J,358.3,6101,1,4,0)
 ;;=4^AMEMIA,ESRD
 ;;^UTILITY(U,$J,358.3,6101,2)
 ;;=^332908
 ;;^UTILITY(U,$J,358.3,6102,0)
 ;;=285.9^^37^433^2
 ;;^UTILITY(U,$J,358.3,6102,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6102,1,3,0)
 ;;=3^285.9
 ;;^UTILITY(U,$J,358.3,6102,1,4,0)
 ;;=4^ANEMIA NOS
 ;;^UTILITY(U,$J,358.3,6102,2)
 ;;=^7007
 ;;^UTILITY(U,$J,358.3,6103,0)
 ;;=413.9^^37^433^4
 ;;^UTILITY(U,$J,358.3,6103,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6103,1,3,0)
 ;;=3^413.9
 ;;^UTILITY(U,$J,358.3,6103,1,4,0)
 ;;=4^ANGINA PECTORIS NEC/NOS
 ;;^UTILITY(U,$J,358.3,6103,2)
 ;;=^87258
 ;;^UTILITY(U,$J,358.3,6104,0)
 ;;=427.9^^37^433^5
 ;;^UTILITY(U,$J,358.3,6104,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6104,1,3,0)
 ;;=3^427.9
 ;;^UTILITY(U,$J,358.3,6104,1,4,0)
 ;;=4^CARDIAC DYSRHYTHMIA NOS
 ;;^UTILITY(U,$J,358.3,6104,2)
 ;;=^10166
 ;;^UTILITY(U,$J,358.3,6105,0)
 ;;=496.^^37^433^6
 ;;^UTILITY(U,$J,358.3,6105,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6105,1,3,0)
 ;;=3^496.
 ;;^UTILITY(U,$J,358.3,6105,1,4,0)
 ;;=4^CHR AIRWAY OBSTRUCT NEC
 ;;^UTILITY(U,$J,358.3,6105,2)
 ;;=^24355
 ;;^UTILITY(U,$J,358.3,6106,0)
 ;;=428.0^^37^433^7
 ;;^UTILITY(U,$J,358.3,6106,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6106,1,3,0)
 ;;=3^428.0
 ;;^UTILITY(U,$J,358.3,6106,1,4,0)
 ;;=4^CONGESTIVE HEART FAILURE
 ;;^UTILITY(U,$J,358.3,6106,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,6107,0)
 ;;=274.9^^37^433^8
 ;;^UTILITY(U,$J,358.3,6107,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6107,1,3,0)
 ;;=3^274.9
 ;;^UTILITY(U,$J,358.3,6107,1,4,0)
 ;;=4^GOUT NOS
 ;;^UTILITY(U,$J,358.3,6107,2)
 ;;=^52625
 ;;^UTILITY(U,$J,358.3,6108,0)
 ;;=274.10^^37^433^9
 ;;^UTILITY(U,$J,358.3,6108,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6108,1,3,0)
 ;;=3^274.10
 ;;^UTILITY(U,$J,358.3,6108,1,4,0)
 ;;=4^GOUTY NEPHROPATHY NOS
 ;;^UTILITY(U,$J,358.3,6108,2)
 ;;=^265113
 ;;^UTILITY(U,$J,358.3,6109,0)
 ;;=272.4^^37^433^10
 ;;^UTILITY(U,$J,358.3,6109,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6109,1,3,0)
 ;;=3^272.4
 ;;^UTILITY(U,$J,358.3,6109,1,4,0)
 ;;=4^HYPERLIPIDEMIA NEC/NOS
 ;;^UTILITY(U,$J,358.3,6109,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,6110,0)
 ;;=252.00^^37^433^12
 ;;^UTILITY(U,$J,358.3,6110,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6110,1,3,0)
 ;;=3^252.00
 ;;^UTILITY(U,$J,358.3,6110,1,4,0)
 ;;=4^HYPERPARATHYROIDISM NOS
 ;;^UTILITY(U,$J,358.3,6110,2)
 ;;=^331438
 ;;^UTILITY(U,$J,358.3,6111,0)
 ;;=588.89^^37^433^11
 ;;^UTILITY(U,$J,358.3,6111,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6111,1,3,0)
 ;;=3^588.89
 ;;^UTILITY(U,$J,358.3,6111,1,4,0)
 ;;=4^HYPERPARATHYROID w/ IMPAIR REN FNC
 ;;^UTILITY(U,$J,358.3,6111,2)
 ;;=^88036
 ;;^UTILITY(U,$J,358.3,6112,0)
 ;;=356.9^^37^433^13
 ;;^UTILITY(U,$J,358.3,6112,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6112,1,3,0)
 ;;=3^356.9
 ;;^UTILITY(U,$J,358.3,6112,1,4,0)
 ;;=4^IDIO PERIPH NEURPTHY NOS
 ;;^UTILITY(U,$J,358.3,6112,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,6113,0)
 ;;=588.89^^37^433^14
 ;;^UTILITY(U,$J,358.3,6113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6113,1,3,0)
 ;;=3^588.89
 ;;^UTILITY(U,$J,358.3,6113,1,4,0)
 ;;=4^IMPAIR REN FUNCT DIS NEC
 ;;^UTILITY(U,$J,358.3,6113,2)
 ;;=^88036
 ;;^UTILITY(U,$J,358.3,6114,0)
 ;;=411.1^^37^433^15
 ;;^UTILITY(U,$J,358.3,6114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6114,1,3,0)
 ;;=3^411.1
 ;;^UTILITY(U,$J,358.3,6114,1,4,0)
 ;;=4^INTERMED CORONARY SYND
 ;;^UTILITY(U,$J,358.3,6114,2)
 ;;=^7455
 ;;^UTILITY(U,$J,358.3,6115,0)
 ;;=428.1^^37^433^16
 ;;^UTILITY(U,$J,358.3,6115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6115,1,3,0)
 ;;=3^428.1
 ;;^UTILITY(U,$J,358.3,6115,1,4,0)
 ;;=4^LEFT HEART FAILURE
 ;;^UTILITY(U,$J,358.3,6115,2)
 ;;=^68721
 ;;^UTILITY(U,$J,358.3,6116,0)
 ;;=581.9^^37^433^17
 ;;^UTILITY(U,$J,358.3,6116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6116,1,3,0)
 ;;=3^581.9
 ;;^UTILITY(U,$J,358.3,6116,1,4,0)
 ;;=4^NEPHROTIC SYNDROME NOS
 ;;^UTILITY(U,$J,358.3,6116,2)
 ;;=^82357
 ;;^UTILITY(U,$J,358.3,6117,0)
 ;;=278.01^^37^433^18
 ;;^UTILITY(U,$J,358.3,6117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6117,1,3,0)
 ;;=3^278.01
 ;;^UTILITY(U,$J,358.3,6117,1,4,0)
 ;;=4^OBESITY,MORBID
 ;;^UTILITY(U,$J,358.3,6117,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,6118,0)
 ;;=278.00^^37^433^19
 ;;^UTILITY(U,$J,358.3,6118,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6118,1,3,0)
 ;;=3^278.00
 ;;^UTILITY(U,$J,358.3,6118,1,4,0)
 ;;=4^OBESITY,UNSPEC
 ;;^UTILITY(U,$J,358.3,6118,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,6119,0)
 ;;=278.02^^37^433^20
 ;;^UTILITY(U,$J,358.3,6119,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6119,1,3,0)
 ;;=3^278.02
 ;;^UTILITY(U,$J,358.3,6119,1,4,0)
 ;;=4^OVERWEIGHT
 ;;^UTILITY(U,$J,358.3,6119,2)
 ;;=^332745
 ;;^UTILITY(U,$J,358.3,6120,0)
 ;;=423.9^^37^433^21
 ;;^UTILITY(U,$J,358.3,6120,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6120,1,3,0)
 ;;=3^423.9
 ;;^UTILITY(U,$J,358.3,6120,1,4,0)
 ;;=4^PERICARDIAL DISEASE NOS
 ;;^UTILITY(U,$J,358.3,6120,2)
 ;;=^123813
 ;;^UTILITY(U,$J,358.3,6121,0)
 ;;=443.9^^37^433^22
 ;;^UTILITY(U,$J,358.3,6121,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6121,1,3,0)
 ;;=3^443.9
 ;;^UTILITY(U,$J,358.3,6121,1,4,0)
 ;;=4^PERIPH VASCULAR DIS NOS
 ;;^UTILITY(U,$J,358.3,6121,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,6122,0)
 ;;=272.0^^37^433^23
 ;;^UTILITY(U,$J,358.3,6122,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6122,1,3,0)
 ;;=3^272.0
 ;;^UTILITY(U,$J,358.3,6122,1,4,0)
 ;;=4^PURE HYPERCHOLESTEROLEM
 ;;^UTILITY(U,$J,358.3,6122,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,6123,0)
 ;;=272.1^^37^433^24
 ;;^UTILITY(U,$J,358.3,6123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6123,1,3,0)
 ;;=3^272.1
